Key Record Dates
ClinicalTrials.gov Identifier: | NCT05463263 |
---|---|
Brief Title: | A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas |
First Submitted : | June 30, 2022 |
First Submitted that Met QC Criteria : | July 14, 2022 |
First Posted : | July 18, 2022 |
Last Update Submitted that Met QC Criteria : | September 19, 2023 |
Last Update Posted : | September 21, 2023 |